Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.
Microplastics: the silent threat – Pharmaceutical Technology
Microplastics, tiny plastic bits less than five millimetres in size, come from breaking down larger plastics and are now everywhere. They are in the air,
February 4, 2025